Glucocorticoid Impaired the Wound Healing Ability of Endothelial Progenitor Cells by Reducing the Expression of CXCR4 in the PGE2 Pathway

Background: Endothelial progenitor cells (EPCs) can be used to treat ischemic disease in cell-based therapy owing to their neovascularization potential. Glucocorticoids (GCs) have been widely used as strong anti-inflammatory reagents. However, despite their beneficial effects, side effects, such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Carolina, Erica, Kato, Toshiki, Khanh, Vuong Cat, Moriguchi, Kana, Yamashita, Toshiharu, Takeuchi, Kosuke, Hamada, Hiromi, Ohneda, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173212/
https://www.ncbi.nlm.nih.gov/pubmed/30324106
http://dx.doi.org/10.3389/fmed.2018.00276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173212/
https://www.ncbi.nlm.nih.gov/pubmed/30324106
http://dx.doi.org/10.3389/fmed.2018.00276

Ejemplares similares